Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Condition(s):Leukemia; Lymphoma; Lymphoproliferative DisorderLast Updated:March 19, 2013Terminated